Carbohydrate engineered cells for regenerative medicine.

Carbohydrate engineered cells for regenerative medicine.
复制标题

DOI:
10.1016/j.addr.2010.01.003
复制
发表时间:
2010-06-15
影响因子:
16.1
通讯作者:
Yarema, Kevin J.
Yarema, Kevin J.
中科院分区:
医学1区
文献类型:
--
作者:
Du, Jian;Yarema, Kevin J.

文献摘要

参考文献

被引文献

相似文献

碳水化合物在几个层面上是干细胞生态位的组成部分;蛋白聚糖是细胞外基质(ECM)的主要成分,糖氨基聚糖(GAGs)帮助细胞连接ECM和邻近细胞,小但信息丰富的低聚糖提供了“糖密码”,识别每个细胞并为其提供独特的功能。这篇文章列举了多糖在发育过程中所扮演的角色,然后描述了代谢糖工程(一种将单糖类似物引入细胞代谢途径并以生物合成方式整合到糖萼中的技术)如何克服了许多长期存在的在活细胞和组织中操纵碳水化合物的障碍,并正在成为组织工程和再生医学的一个有趣的新工具。
Carbohydrates are integral components of the stem cell niche on several levels; proteoglycans are a major constituent of the extracellular matrix (ECM) surrounding a cell, glycosoaminoglycans (GAGs) help link cells to the ECM and the neighboring cells, and small but informationally-rich oligosaccharides provide a “sugar code” that identifies each cell and provides it with unique functions. This article samples roles that glycans play in development and then describes how metabolic glycoengineering – a technique where monosaccharide analogs are introduced into the metabolic pathways of a cell and are biosynthetically incorporated into the glycocalyx – is overcoming many of the long-standing barriers to manipulating carbohydrates in living cells and tissues and is becoming an intriguing new tool for tissue engineering and regenerative medicine.
DOI: 10.1021/jm800873k
发表时间: 2008-12-25
影响因子: 7.3
作者:
Campbell CT;Aich U;Weier CA;Wang JJ;Choi SS;Wen MM;Maisel K;Sampathkumar SG;Yarema KJ
通讯作者: Yarema KJ
DOI: 10.1002/cbic.200400162
发表时间: 2004-10-04
期刊: CHEMBIOCHEM
影响因子: 3.2
作者:
Cohen, M;Joester, D;Addadi, L
通讯作者: Addadi, L
DOI: 10.1002/bit.10525
发表时间: 2003-03-30
影响因子: 3.8
作者:
De Bank, PA;Kellam, B;Shakesheff, KM
通讯作者: Shakesheff, KM
DOI: 10.1126/science.1171643
发表时间: 2009-06-26
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Discher DE;Mooney DJ;Zandstra PW
通讯作者: Zandstra PW
DOI: 10.1093/glycob/10.1.11
发表时间: 2000-01-01
期刊: GLYCOBIOLOGY
影响因子: 4.3
作者:
Collins, BE;Fralich, TJ;Schnaar, RL
通讯作者: Schnaar, RL